Clinical Trial Update: Duobrii in Combination With Biologics [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update evaluating Duobrii in combination with biologics for psoriasis, currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis

Drugs mentioned

• Duobrii (halobetasol propionate and tazarotene)

Snippet

Sponsor: Psoriasis Treatment Center of Central New Jersey | Conditions: Psoriasis | Phase 4 | Status: RECRUITING